Rhythm Pharmaceuticals (RYTM) Finished Goods (2021 - 2025)
Rhythm Pharmaceuticals (RYTM) posted quarterly Finished Goods of $14.5 million for Q3 2025, up 80.97% year-over-year from $8.0 million in Q3 2024, and up 6.7% quarter-over-quarter from $13.6 million in Q2 2025.
Rhythm Pharmaceuticals (RYTM) Finished Goods (2021 - 2025) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Finished Goods for 5 consecutive years, with $14.5 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Finished Goods rose 80.97% year-over-year to $14.5 million; the TTM figure through Sep 2025 stood at $14.5 million (up 80.97% YoY), while the FY2024 annual figure was $10.7 million, up 270.12% from the prior year.
- Finished Goods improved to $14.5 million in Q3 2025 per RYTM's latest filing, from $13.6 million in the prior quarter.
- Across five years, Finished Goods topped out at $14.5 million in Q3 2025 and bottomed at $111000.0 in Q4 2021.
- Historically, Finished Goods has averaged $5.7 million across 5 years, with a median of $2.9 million in 2023.
- Annual changes were most pronounced in 2022 — Finished Goods soared 75.68% — and 2023, when it soared 1384.62%.
- Rhythm Pharmaceuticals' Finished Goods stood at $111000.0 in 2021, then jumped by 75.68% to $195000.0 in 2022, then jumped by 1384.62% to $2.9 million in 2023, then soared by 270.12% to $10.7 million in 2024, then surged by 35.71% to $14.5 million in 2025.
- Business Quant data shows RYTM's Finished Goods at $14.5 million in Q3 2025, $13.6 million in Q2 2025, and $12.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.54 Mn |
| Jun 30, 2025 | 13.63 Mn |
| Mar 31, 2025 | 12.60 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 957,000.00 |
| Mar 31, 2023 | 791,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Dec 31, 2021 | 111,000.00 |